Gabapentin Capsule
Product Images NDC 71335-3140

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-3140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
This text seems to be a chart showing the comparison of pain scores over the course of a study involving placebo and two doses of Gabapentin (1800 mg/day and 2400 mg/day) over a 4-week fixed dose period. The mean pain score decreases over time, with measurements taken at baseline and weekly intervals.*
FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Image-04 (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Image-09 (Image 09)

Image-09 (Image 09)
This text provides information about doses in milligrams ranging from 0 to 1600, which can be useful to understand the recommended daily intake of a particular substance.*
FDA Label Image

Label (Lbl713353140)

Label (Lbl713353140)
This is a medication label for Gabapentin capsules containing 100 mg each. It includes storage instructions, precautions about dizziness, and guidance for pharmacists to provide a medication guide to each patient. The label also mentions the manufacturer as ScisGen Pharmaceuticals, Inc. and provides a QR code for detailed prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.